Ndadza A.
University of Cape Town
South Africa
About
No AI summary yet.
Metrics
- Publications
- 12
- Citations
- 136
- h-index
- 6
- Publishing journals
- 9
- Years of publications
- 8
- Active since
- 2018
- References
- 632
- Institutions
- 3
Publication history
Latest publications
- Very low prevalence of validated kelch13 mutations and absence of hrp2/3 double gene deletions in South African malaria-eliminating districts (2022-2024)
- Whole-Exome Sequencing for Molecular Diagnosis of Paediatric Nephrotic Syndrome in Africa: A Call for Implementation.
- Very Low Prevalence of Validated kelch13 Mutations and Absence of Histidine-Rich Protein 2/3 Double Gene Deletions in South African Malaria-Eliminating Districts (2022–2024)
- Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry
- Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes
- The importance of including African populations in pharmacogenetics studies of warfarin response
- Profiling of warfarin pharmacokinetics‐associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics‐dosing algorithm
- Childhood Obesity Risk in Relationship to Perilipin 1 ( PLIN1 ) Gene Regulation by Circulating microRNAs
- The Genetics of Warfarin Dose–Response Variability in Africans: An Expert Perspective on Past, Present, and Future
- Warfarin Dose and CYP2C Gene Cluster: An African Ancestral-Specific Variant Is a Strong Predictor of Dose in Black South African Patients
- Rotavirus strain diversity in Eastern and Southern African countries before and after vaccine introduction
- Unique Profile of Pharmacogenetics Variants Associated With Warfarin Response In Black Africans: Looking Beyond VKORC1 and CYP2C9 Polymorphisms
No publications in the index yet.